Minimum infective dose of Mycobacterium bovis in cattle

Infection and Immunity

Volumn 73, Issue 10, 2005, Pages 6467-6471

  Dean, Gillian S ^a   Rhodes, Shelley G ^a   Coad, Michael ^a   Whelan, Adam O ^a   Cockle, Paul J ^a   Clifford, Derek J ^a   Hewinson, R Glyn ^a   Vordermeier, H Martin ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MYCOBACTERIUM ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD SAMPLING; CATTLE DISEASE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMMUNE RESPONSE; INOCULATION; MICROBIOLOGICAL EXAMINATION; MINIMUM INFECTIVE DOSE; MYCOBACTERIUM BOVIS; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RISK ASSESSMENT; TUBERCULIN TEST;

ANIMALS; CATTLE; INTERFERON TYPE II; INTERLEUKIN-4; LUNG; MYCOBACTERIUM BOVIS; TUBERCULIN TEST; TUBERCULOSIS, BOVINE;

EID: 25444440593     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.10.6467-6471.2005     Document Type: Article

References (30)

1. Anonymous. 2002. European Commission Regulation (EC) NO 1226/2002 of 8 July 2002 amending annex B to Council Directive 64/432/EEC. Off. J. Eur. Union (English) L 179:13.
2. Buddle, B. M., G. W. DeLisle, A. Pfeffer, and F. E. Aldwell. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13:1123-1130.
3. Buddle, B. M., D. Keen, A. Thomson, G. Jowett, A. R. McCarthy, J. Heslop, G. W. DeLisle, J. L. Stanford, and F. E. Aldwell. 1995. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res. Vet. Sci. 59:10-16.
4. Buddle, B. M., N. A. Parlane, D. L. Keen, F. E. Aldwell, J. M. Pollock, K. Lightbody, and P. Andersen. 1999. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. Clin. Diag. Lab. Immunol. 6:1-5.
5. Chaussé, P. 1913. Des méthodes à employer pour réaliser la tuberculose expérimentale par inhalation. Bull. Soc. Med. Vet. 31:267-274.
6. Corner, L. A. 1994. Post mortem diagnosis of Mycobacterium bovis infection in cattle. Vet. Microbiol. 40:53-63.
7. Daborn, C. J., J. M. Grange, and R. R. Kazwala. 1996. The bovine tuberculosis cycle: an African perspective. Soc. Appl. Bacteriol. Symp. Ser. 25:27S-32S.
8. Demissie, A., M. Abebe, A. Aseffa, G. Rook, H. Fletcher, A. Zumla, K. Weldingh, I. Brock, P. Andersen, T. M. Doherty, and the VACSEL Study Group. 2004. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-482. J. Immunol. 172:6938-6943.
9. Emery, D. L., F. H. Duffy, and P. R. Wood. 1988. An analysis of cellular proliferation and synthesis of lymphokines and specific antibody in vitro by leucocytes from immunized cattle. Vet. Immunol. Immunopathol. 18:67-80.
10. Francis J. 1947. Bovine tuberculosis, including a contrast with human tuberculosis. Staples Press Ltd., London, United Kingdom.
11. Hardie, R. M., and J. M. Watson. 1992. Mycobacterium bovis in England and Wales: past, present and future. Epidemiol. Infect. 109:23-33.
12. Kuhnle, G., R. A. Collins, J. E. Scott, and G. M. Keil. 1996. Bovine interleukin-2 and interleukin-4 expressed in recombinant bovine herpesvirus-1 are biologically active secreted glycoproteins. J. Gen. Virol. 77:2231-2240.
13. Lyashchenko, K., A. O. Whelan, R. Greenwald, J. M. Pollock, P. Andersen, R. G. Hewinson, and H. M. Vordermeier. 2004. Association of tuberculin-boosted antibody response with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis. Infect. Immun. 72:2462-2467.
14. McCorry, T. A., A. O. Whelan, M. D. Welsh, J. McNair, E. Walton, D. G. Bryson, R. G. Hewinson, and H. M. Vordermeier. Shedding of Mycobacterium bovis in the nasal mucus of cattle experimentally infected with tuberculosis by the intranasal and intratracheal routes. Vet. Rec., in press.
15. McFadyean, J. 1910. What is the common method of infection in tuberculosis? J. Comp. Pathol. 23:239-250 and 289-298.
16. Morrison, W. I., F. J. Bourne, D. R. Cox, C. A. Donnelly, G. Gettinby, J. P. McInerney, and R. Woodroffe. 2000. Pathogenesis and diagnosis of infections with Mycobacterium bovis in cattle. Vet. Rec. 26:236-242.
17. Neill, S. D., J. Hanna, J. J. O'Brien, and R. M. McCracken. 1988. Excretion of Mycobacterium bovis by experimentally infected cattle. Vet. Rec. 123:340-343.
18. Neill, S. D., J. J. O'Brien, and J. Hanna. 1991. A mathematical model for Mycobacterium bovis excretion from tuberculous cattle. Vet. Microbiol. 28:103-109.
19. Neill, S. D., J. M. Pollock, D. B. Bryson, and J. Hanna. 1994. Pathogenesis of Mycobacterium bovis infection in cattle. Vet. Microbiol. 40:41-52.
20. Ng, K. H., F. E. Aldwell, D. N. Wedlock, J. D. Watson, and B. M. Buddle. 1997. Antigen-induced interferon-gamma and interleukin-2 responses of cattle inoculated with Mycobacterium bovis. Vet. Immunol. Immunopathol. 57:59-68.
21. O'Grady, F., and R. L. Riley. 1963. Experimental airborne tuberculosis. Adv. Tuberc. Res. 12:150-190.
22. + T cells in response to bovine viral diarrhoea virus in cattle. J. Gen. Virol. 80:1673-1679.
23. Rhodes, S. G., N. Palmer, S. P. Graham, A. E. Bianco, R. G. Hewinson, and H. M. Vordermeier. 2000. Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis. Infect. Immun. 68:5393-5400.
24. Rich, A. R. 1946. Pathogenesis of tuberculosis. Thomas, Springfield, 111.
25. Riley, R. L., C. C. Mills, W. Nyka, N. Weinstock, P. B. Storey, L. U. Sultan, M. C. Riley, and W. F. Wells. 1995. Aerial dissemination of pulmonary tuberculosis. A two year study of contagion in a tuberculosis ward, 1959. Am. J. Epidemiol. 142:3-14.
26. Rook, G. A. W., R. Hernandez-Pando, K. Dheda, and G. T. Seah. 2004. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol. 25:483-488.
27. Sonin, L. S. 1951. The role of particle size in experimental airborne infection. Am. J. Hyg. 53:337-354.
28. Vordermeier, H. M., M. A. Chambers, P. J. Cockle, A. O. Whelan, J. Simmons, and R. G. Hewinson. 2002. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70:3026-3032.
29. Vordermeier, H. M., A. Whelan, P. J. Cockle, L. Farrant, N. Palmer, and R. G. Hewinson. 2001. The use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diag. Lab. Immunol. 8:571-578.
30. Whipple, D. L., C. A. Bolin, and J. M. Miller. 1996. Distribution of lesions in cattle infected with Mycobacterium bovis. J. Vet. Diagn. Investig. 8:351-354.